OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 61 filers reported holding OYSTER PT PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $123,507 | +62.5% | 11,057 | -17.8% | 0.00% | – |
| Q3 2022 | $76,000 | +4.1% | 13,451 | -20.3% | 0.00% | – |
| Q2 2022 | $73,000 | -74.5% | 16,870 | -31.3% | 0.00% | – |
| Q1 2022 | $286,000 | -44.7% | 24,563 | -13.2% | 0.00% | – |
| Q4 2021 | $517,000 | +1048.9% | 28,300 | +659.1% | 0.00% | – |
| Q3 2021 | $45,000 | -37.5% | 3,728 | -11.3% | 0.00% | – |
| Q2 2021 | $72,000 | -25.0% | 4,202 | -20.1% | 0.00% | – |
| Q1 2021 | $96,000 | +9.1% | 5,261 | +12.7% | 0.00% | – |
| Q4 2020 | $88,000 | -15.4% | 4,669 | -6.1% | 0.00% | – |
| Q3 2020 | $104,000 | -9.6% | 4,970 | +24.5% | 0.00% | – |
| Q2 2020 | $115,000 | +57.5% | 3,993 | +91.3% | 0.00% | – |
| Q1 2020 | $73,000 | +217.4% | 2,087 | +123.2% | 0.00% | – |
| Q4 2019 | $23,000 | – | 935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |